Healthcare -
Biotechnology - NYSE - DK
$ 78.69
-5.27 %
$ 349 B
Market Cap
26.86
P/E
NVO - TAX PROVISION
Tax Provision NVO - Novo Nordisk A/S
21 B
LAST VALUE
36.16%
2 YEAR CAGR
18.49%
5 YEAR CAGR
11.06%
10 YEAR CAGR